GSK PLC (GSK) — Hedge Fund Ownership Q4 2025
GSK
- GSK PLC (GSK) is held by 7 of 81 tracked hedge funds, with Hillman Capital Management (4%) and Dodge & Cox (2%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest increases in GSK holdings came from Pzena Investment Management (+54%), highlighting conviction.
- The biggest decreases in GSK holdings came from Dodge & Cox (-13%) and Causeway Capital Management (-97%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to GSK PLC (GSK) by -14% vs the prior quarter and -3% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Hillman Capital Management Mark Hillman
|
3.53% | 114K | -19.36% | -50.54% | $5.6M | $49.04 | — |
| 2 |
Dodge & Cox
|
1.81% | 68.5M | -12.61% | +0.11% | $3.36B | $49.04 | — |
| 3 |
Kahn Brothers Group Irving Kahn
|
1.55% | 179K | -31.49% | -79.80% | $8.8M | $49.04 | — |
| 4 |
Third Avenue Management
|
0.33% | 82K | — | -12.34% | $4.0M | $49.04 | — |
| 5 |
Tweedy, Browne Tweedy, Browne Co LLC
|
0.33% | 82K | — | -12.34% | $4.0M | $49.04 | — |
| 6 |
Causeway Capital Management
|
0.02% | 34K | -97.12% | -96.85% | $1.7M | $49.04 | — |
| 7 |
Pzena Investment Management Richard Pzena
|
0.00% | 13K | +54.23% | — | $659,292 | $49.04 | — |
| 7 | Total | — | 69.0M | -13.89% | -2.56% | $3.38B | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.